These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36281514)

  • 21. Emergence of colistin resistance in Pseudomonas aeruginosa ST235 clone in South Korea.
    Wi YM; Choi JY; Lee JY; Kang CI; Chung DR; Peck KR; Song JH; Ko KS
    Int J Antimicrob Agents; 2017 Jun; 49(6):767-769. PubMed ID: 28392440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular characterisation of carbapenem-resistant Pseudomonas aeruginosa clinical isolates in Nepal.
    Takahashi T; Tada T; Shrestha S; Hishinuma T; Sherchan JB; Tohya M; Kirikae T; Sherchand JB
    J Glob Antimicrob Resist; 2021 Sep; 26():279-284. PubMed ID: 34284125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neonatal sepsis due to NDM-1 and VIM-2 co-producing Pseudomonas aeruginosa in Morocco.
    Daaboul D; Osman M; Kassem II; Yassine I; Girlich D; Proust A; Mounir C; Zerouali K; Raymond J; Naas T; Oueslati S
    J Antimicrob Chemother; 2024 Jul; 79(7):1614-1618. PubMed ID: 38804143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection and characterisation of 16S rRNA methyltransferase-producing Pseudomonas aeruginosa from the UK and Republic of Ireland from 2003-2015.
    Taylor E; Jauneikaite E; Sriskandan S; Woodford N; Hopkins KL
    Int J Antimicrob Agents; 2022 Mar; 59(3):106550. PubMed ID: 35176475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of extended spectrum beta-lactamases, metallo-beta-lactamases and AmpC-beta-lactamases among carbapenem resistant Pseudomonas aeruginosa isolated from burn patients.
    Neyestanaki DK; Mirsalehian A; Rezagholizadeh F; Jabalameli F; Taherikalani M; Emaneini M
    Burns; 2014 Dec; 40(8):1556-61. PubMed ID: 24767143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of carbapenem-resistant and XDR Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-16 study.
    McCracken MG; Adam HJ; Blondeau JM; Walkty AJ; Karlowsky JA; Hoban DJ; Zhanel GG; Mulvey MR;
    J Antimicrob Chemother; 2019 Aug; 74(Suppl 4):iv32-iv38. PubMed ID: 31505643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Italian nationwide survey on Pseudomonas aeruginosa from invasive infections: activity of ceftolozane/tazobactam and comparators, and molecular epidemiology of carbapenemase producers.
    Giani T; Arena F; Pollini S; Di Pilato V; D'Andrea MM; Henrici De Angelis L; Bassetti M; Rossolini GM;
    J Antimicrob Chemother; 2018 Mar; 73(3):664-671. PubMed ID: 29216350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Characterization of Multidrug-Resistant
    Tada T; Hishinuma T; Watanabe S; Uchida H; Tohya M; Kuwahara-Arai K; Mya S; Zan KN; Kirikae T; Tin HH
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30803967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EDTA-modified carbapenem inactivation method (eCIM) for detecting IMP Metallo-β-lactamase-producing Pseudomonas aeruginosa: an assessment of increasing EDTA concentrations.
    Lasko MJ; Gill CM; Asempa TE; Nicolau DP
    BMC Microbiol; 2020 Jul; 20(1):220. PubMed ID: 32690021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic epidemiology and molecular characteristics of bla
    Jung H; Pitout JDD; Matsumura Y; Strydom KA; Kingsburgh C; Ehlers MM; Kock MM
    Eur J Clin Microbiol Infect Dis; 2024 Apr; 43(4):627-640. PubMed ID: 38265603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dissemination of genetically related IMP-6-producing multidrug-resistant Pseudomonas aeruginosa ST235 in South Korea.
    Yoo JS; Yang JW; Kim HM; Byeon J; Kim HS; Yoo JI; Chung GT; Lee YS
    Int J Antimicrob Agents; 2012 Apr; 39(4):300-4. PubMed ID: 22325122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissemination of Carbapenem-resistant Klebsiella pneumoniae clinical isolates with various combinations of Carbapenemases (KPC-2, NDM-1, NDM-4, and OXA-48) and 16S rRNA Methylases (RmtB and RmtC) in Vietnam.
    Tada T; Tsuchiya M; Shimada K; Nga TTT; Thu LTA; Phu TT; Ohmagari N; Kirikae T
    BMC Infect Dis; 2017 Jul; 17(1):467. PubMed ID: 28676118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of VIM-2-, IMP-1- and NDM-1-producing multidrug-resistant Pseudomonas aeruginosa in Malaysia.
    Liew SM; Rajasekaram G; Puthucheary SD; Chua KH
    J Glob Antimicrob Resist; 2018 Jun; 13():271-273. PubMed ID: 29432937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clonal spread of IMP-1-producing Pseudomonas aeruginosa in two hospitals in Singapore.
    Koh TH; Wang GC; Sng LH
    J Clin Microbiol; 2004 Nov; 42(11):5378-80. PubMed ID: 15528748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dissemination of an international high-risk clone of Escherichia coli ST410 co-producing NDM-5 and OXA-181 carbapenemases in Seoul, Republic of Korea.
    Kim JS; Yu JK; Jeon SJ; Park SH; Han S; Park SH; Kang M; Jang JI; Park J; Shin EK; Kim J; Hong CK; Lee JH; Hwang YO; Oh YH
    Int J Antimicrob Agents; 2021 Dec; 58(6):106448. PubMed ID: 34648943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbapenem inactivation: a very affordable and highly specific method for phenotypic detection of carbapenemase-producing Pseudomonas aeruginosa isolates compared with other methods.
    Akhi MT; Khalili Y; Ghotaslou R; Kafil HS; Yousefi S; Nagili B; Goli HR
    J Chemother; 2017 Jun; 29(3):144-149. PubMed ID: 27443547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nationwide epidemiology of carbapenem resistant Klebsiella pneumoniae isolates from Greek hospitals, with regards to plazomicin and aminoglycoside resistance.
    Galani I; Nafplioti K; Adamou P; Karaiskos I; Giamarellou H; Souli M;
    BMC Infect Dis; 2019 Feb; 19(1):167. PubMed ID: 30770727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergence of Imipenem-Resistant Pseudomonas aeruginosa Clinical Isolates from Egypt Coharboring VIM and IMP Carbapenemases.
    El-Domany RA; Emara M; El-Magd MA; Moustafa WH; Abdeltwab NM
    Microb Drug Resist; 2017 Sep; 23(6):682-686. PubMed ID: 28085553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New Delhi Metallo-β-Lactamase 1(NDM-1), the Dominant Carbapenemase Detected in Carbapenem-Resistant Enterobacter cloacae from Henan Province, China.
    Liu C; Qin S; Xu H; Xu L; Zhao D; Liu X; Lang S; Feng X; Liu HM
    PLoS One; 2015; 10(8):e0135044. PubMed ID: 26263489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbapenemase -producing Pseudomonas aeruginosa isolates from Turkey: first report of P. aeruginosa high-risk clones with VIM-5- and IMP-7-type carbapenemases in a tertiary hospital.
    Çekin ZK; Dabos L; Malkoçoğlu G; Fortineau N; Bayraktar B; Iorga BI; Naas T; Aktaş E
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115174. PubMed ID: 32980808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.